Phase 1 Trial of Autologous Bone Marrow Stem Cell Transplantation in Patients with Spinal Cord Injury

Introduction. A total of 18 patients, with complete motor deficits and paraplegia caused by thoracic and lumbar spine trauma without muscle atrophy or psychiatric problems, were included into this study. Materials and Methods. The bone marrow was aspirated from the anterior iliac crest under local a...

Full description

Saved in:
Bibliographic Details
Main Authors: Zurab Kakabadze, Nickolas Kipshidze, Konstantine Mardaleishvili, Gocha Chutkerashvili, Irakli Chelishvili, Albrecht Harders, George Loladze, Gocha Shatirishvili, Nodar Kipshidze, David Chakhunashvili, Konstantine Chutkerashvili
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2016/6768274
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552648025309184
author Zurab Kakabadze
Nickolas Kipshidze
Konstantine Mardaleishvili
Gocha Chutkerashvili
Irakli Chelishvili
Albrecht Harders
George Loladze
Gocha Shatirishvili
Nodar Kipshidze
David Chakhunashvili
Konstantine Chutkerashvili
author_facet Zurab Kakabadze
Nickolas Kipshidze
Konstantine Mardaleishvili
Gocha Chutkerashvili
Irakli Chelishvili
Albrecht Harders
George Loladze
Gocha Shatirishvili
Nodar Kipshidze
David Chakhunashvili
Konstantine Chutkerashvili
author_sort Zurab Kakabadze
collection DOAJ
description Introduction. A total of 18 patients, with complete motor deficits and paraplegia caused by thoracic and lumbar spine trauma without muscle atrophy or psychiatric problems, were included into this study. Materials and Methods. The bone marrow was aspirated from the anterior iliac crest under local anesthesia and the mononuclear fraction was isolated by density gradient method. At least 750 million mononuclear-enriched cells, suspended in 2 mL of saline, were infused intrathecally. Results and Discussion. The study reports demonstrated improvement of motor and sensory functions of various degrees observed in 9 of the 18 (50%) cases after bone marrow stem cell transplantation. Measured by the American Spinal Injury Association (ASIA) scale, 7 (78%) out of the 9 patients observed an improvement by one grade, while two cases (22%) saw an improvement by two grades. However, there were no cases in which the condition was improved by three grades. Conclusions. Analysis of subsequent treatment results indicated that the transplantation of mononuclear-enriched autologous BMSCs is a feasible and safe technique. However, successful application of the BMSCs in the clinical practice is associated with the necessity of executing more detailed examinations to evaluate the effect of BMSCs on the patients with spinal cord injury.
format Article
id doaj-art-6d6d76124e7c4931950738a9707ca979
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-6d6d76124e7c4931950738a9707ca9792025-02-03T05:58:16ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/67682746768274Phase 1 Trial of Autologous Bone Marrow Stem Cell Transplantation in Patients with Spinal Cord InjuryZurab Kakabadze0Nickolas Kipshidze1Konstantine Mardaleishvili2Gocha Chutkerashvili3Irakli Chelishvili4Albrecht Harders5George Loladze6Gocha Shatirishvili7Nodar Kipshidze8David Chakhunashvili9Konstantine Chutkerashvili10Department of Clinical Anatomy, Tbilisi State Medical University, 0177 Tbilisi, GeorgiaN. Kipshidze Central University Hospital, 0177 Tbilisi, GeorgiaDepartment of Cell Therapy and Cancer Immunotherapy, Cancer Research Centre, 0177 Tbilisi, GeorgiaDepartment of Cell Therapy and Cancer Immunotherapy, Cancer Research Centre, 0177 Tbilisi, GeorgiaDepartment of Neurosurgery, Archangel St. Michael Multi Profile Clinical Hospital, 0112 Tbilisi, GeorgiaDepartment of Neurosurgery, Ruhr University Bochum, 44801 Bochum, GermanyDepartment of Cell Therapy and Cancer Immunotherapy, Cancer Research Centre, 0177 Tbilisi, GeorgiaDepartment of Cell Therapy and Cancer Immunotherapy, Cancer Research Centre, 0177 Tbilisi, GeorgiaN. Kipshidze Central University Hospital, 0177 Tbilisi, GeorgiaDepartment of Clinical Anatomy, Tbilisi State Medical University, 0177 Tbilisi, GeorgiaDepartment of Clinical Anatomy, Tbilisi State Medical University, 0177 Tbilisi, GeorgiaIntroduction. A total of 18 patients, with complete motor deficits and paraplegia caused by thoracic and lumbar spine trauma without muscle atrophy or psychiatric problems, were included into this study. Materials and Methods. The bone marrow was aspirated from the anterior iliac crest under local anesthesia and the mononuclear fraction was isolated by density gradient method. At least 750 million mononuclear-enriched cells, suspended in 2 mL of saline, were infused intrathecally. Results and Discussion. The study reports demonstrated improvement of motor and sensory functions of various degrees observed in 9 of the 18 (50%) cases after bone marrow stem cell transplantation. Measured by the American Spinal Injury Association (ASIA) scale, 7 (78%) out of the 9 patients observed an improvement by one grade, while two cases (22%) saw an improvement by two grades. However, there were no cases in which the condition was improved by three grades. Conclusions. Analysis of subsequent treatment results indicated that the transplantation of mononuclear-enriched autologous BMSCs is a feasible and safe technique. However, successful application of the BMSCs in the clinical practice is associated with the necessity of executing more detailed examinations to evaluate the effect of BMSCs on the patients with spinal cord injury.http://dx.doi.org/10.1155/2016/6768274
spellingShingle Zurab Kakabadze
Nickolas Kipshidze
Konstantine Mardaleishvili
Gocha Chutkerashvili
Irakli Chelishvili
Albrecht Harders
George Loladze
Gocha Shatirishvili
Nodar Kipshidze
David Chakhunashvili
Konstantine Chutkerashvili
Phase 1 Trial of Autologous Bone Marrow Stem Cell Transplantation in Patients with Spinal Cord Injury
Stem Cells International
title Phase 1 Trial of Autologous Bone Marrow Stem Cell Transplantation in Patients with Spinal Cord Injury
title_full Phase 1 Trial of Autologous Bone Marrow Stem Cell Transplantation in Patients with Spinal Cord Injury
title_fullStr Phase 1 Trial of Autologous Bone Marrow Stem Cell Transplantation in Patients with Spinal Cord Injury
title_full_unstemmed Phase 1 Trial of Autologous Bone Marrow Stem Cell Transplantation in Patients with Spinal Cord Injury
title_short Phase 1 Trial of Autologous Bone Marrow Stem Cell Transplantation in Patients with Spinal Cord Injury
title_sort phase 1 trial of autologous bone marrow stem cell transplantation in patients with spinal cord injury
url http://dx.doi.org/10.1155/2016/6768274
work_keys_str_mv AT zurabkakabadze phase1trialofautologousbonemarrowstemcelltransplantationinpatientswithspinalcordinjury
AT nickolaskipshidze phase1trialofautologousbonemarrowstemcelltransplantationinpatientswithspinalcordinjury
AT konstantinemardaleishvili phase1trialofautologousbonemarrowstemcelltransplantationinpatientswithspinalcordinjury
AT gochachutkerashvili phase1trialofautologousbonemarrowstemcelltransplantationinpatientswithspinalcordinjury
AT iraklichelishvili phase1trialofautologousbonemarrowstemcelltransplantationinpatientswithspinalcordinjury
AT albrechtharders phase1trialofautologousbonemarrowstemcelltransplantationinpatientswithspinalcordinjury
AT georgeloladze phase1trialofautologousbonemarrowstemcelltransplantationinpatientswithspinalcordinjury
AT gochashatirishvili phase1trialofautologousbonemarrowstemcelltransplantationinpatientswithspinalcordinjury
AT nodarkipshidze phase1trialofautologousbonemarrowstemcelltransplantationinpatientswithspinalcordinjury
AT davidchakhunashvili phase1trialofautologousbonemarrowstemcelltransplantationinpatientswithspinalcordinjury
AT konstantinechutkerashvili phase1trialofautologousbonemarrowstemcelltransplantationinpatientswithspinalcordinjury